Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA Revises Guidance Best Practices, Declines Detailed Public Comment Summaries
Dec 02 2024
•
By
Sue Sutter
The FDA is implementing some new best practices for guidance documents.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Approval Standards
More from Pathways & Standards